Literature DB >> 12137862

Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity.

Alberto Falorni1, Stefano Laureti, Paola Candeloro, Silvia Perrino, Concetta Coronella, Antonio Bizzarro, Antonio Bellastella, Fausto Santeusanio, Annamaria De Bellis.   

Abstract

OBJECTIVE: To determine the prevalence of steroid-cell autoantibodies, 3beta-hydroxysteroid dehydrogenase (3beta-HSD) antibodies, 17alpha-hydroxylase (17alpha-OH) antibodies, and P450 side-chain cleavage antibodies in premature ovarian failure.
DESIGN: Cross-sectional, observational study.
SETTING: Academic research hospitals. PATIENT(S): Eighty-one women with premature ovarian failure, 20 women with Addison disease not associated with premature ovarian failure, 42 women with type 1 diabetes mellitus, and 90 healthy women. MAIN OUTCOME MEASURE(S): Serum levels of steroid-cell autoantibodies, 17alpha-OH antibodies, P450 side-chain cleavage antibodies, and 3beta-HSD antibodies. RESULT(S): Steroid-cell autoantibodies were present in none of 57 women with isolated premature ovarian failure or premature ovarian failure plus nonadrenal autoimmune disease and in 21 of 24 (87%) women with Addison disease-related premature ovarian failure. 17alpha-Hydroxylase antibodies and P450 side-chain cleavage antibodies were significantly more frequent in women positive for adrenal autoantibodies than in those negative for adrenal autoantibodies (50% vs. 0% and 71% vs. 2%, respectively). The presence of 17alpha-OH antibodies or P450 side-chain cleavage antibodies was strongly associated with presence of steroid-cell autoantibodies. Two of 24 (8%) women with Addison disease-related premature ovarian failure and 1 of 57 (2%) women with isolated premature ovarian failure or premature ovarian failure plus nonadrenal autoimmune disease were positive for 3beta-HSD antibodies. None of 20 adult women with autoimmune Addison disease and none of 42 adult women with type 1 diabetes mellitus not associated with premature ovarian failure was positive for 3beta-HSD antibodies. CONCLUSION(S): Markers of steroid-cell autoimmunity are found only rarely in idiopathic premature ovarian failure not associated with Addison disease. Most women with Addison disease-related premature ovarian failure were positive for steroid-cell autoantibodies, 17alpha-OH antibodies, or P450 side-chain cleavage antibodies. 3beta-Hydroxysteroid dehydrogenase antibodies do not appear to be a major marker of steroid-cell autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137862     DOI: 10.1016/s0015-0282(02)03205-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Mechanisms and models of immune tolerance breakdown in the ovary.

Authors:  Mickie H Cheng; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.

Authors:  Seby L Edassery; Seerin V Shatavi; Jeremy P Kunkel; Charles Hauer; Cosima Brucker; Krishna Penumatsa; Yi Yu; James A Dias; Judith L Luborsky
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

Review 3.  Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update.

Authors:  Eusebio S Pires
Journal:  J Assist Reprod Genet       Date:  2010-06-03       Impact factor: 3.412

4.  Autoimmune Regulator is required in female mice for optimal embryonic development and implantation†.

Authors:  Bryce D Warren; Soo H Ahn; Lynda K McGinnis; Geoffrey Grzesiak; Ren-Wei Su; Asgerally T Fazleabas; Lane K Christenson; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

Review 5.  Fertility and pregnancy in women with primary adrenal insufficiency.

Authors:  Sophie Bensing; Roberta Giordano; Alberto Falorni
Journal:  Endocrine       Date:  2020-05-29       Impact factor: 3.633

Review 6.  Ovarian autoimmune disease: clinical concepts and animal models.

Authors:  Bryce D Warren; William K Kinsey; Lynda K McGinnis; Lane K Christenson; Susmita Jasti; Anne M Stevens; Brian K Petroff; Margaret G Petroff
Journal:  Cell Mol Immunol       Date:  2014-10-20       Impact factor: 11.530

Review 7.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

Review 8.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

Review 9.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

10.  Primary Ovarian Insufficiency in Women With Addison's Disease.

Authors:  Elinor C Vogt; Lars Breivik; Ellen C Røyrvik; Marianne Grytaas; Eystein S Husebye; Marianne Øksnes
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.